Journal of Substance Abuse Treatment

Papers
(The TQCC of Journal of Substance Abuse Treatment is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study104
A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, he97
The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder93
The impact of COVID-19 on health care professionals who are exposed to drug-related deaths while supporting clients experiencing addiction92
Substance use among women who are pregnant: Examining treatment completion by race and ethnicity82
Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose75
Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine66
SMART Recovery International and COVID-19: Expanding the reach of mutual support through online groups62
Patterns of enrollment in a New Orleans women's substance use rehabilitation center52
C2: editorial board51
TOC (update)49
C2: editorial board47
Associations between prescription and illicit stimulant and opioid use in the United States, 2015–202046
C2: editorial board45
Suicidal behavior, opioid use disorder, and behavioral health treatment: Prevalence and correlates among adults in the United States 2015–201845
C2: editorial board45
JSAT call for papers for special issue: Stimulant use disorder40
C2: editorial board39
Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings39
Influence of a national transgender health care directive on receipt of alcohol-related care among transgender Veteran Health Administration patients with unhealthy alcohol use39
Substance use disorders among older populations: What role do race and ethnicity play in treatment and completion?39
The intersection of race and opioid use disorder treatment: A quantitative analysis38
Association between discharges against medical advice and readmission in patients treated for drug injection-related skin and soft tissue infections37
Associations between patient experience and clinical outcomes in substance use disorder clinics: Findings from the veterans outcomes assessment survey37
Predicting longitudinal service use for individuals with substance use disorders: A latent profile analysis35
Opioid-related emergencies in New York City after the Great Recession35
Negative affect-associated drug refusal self-efficacy, illicit opioid use, and medication use following short-term inpatient opioid withdrawal management35
Where did the specialty behavioral health workforce grow between 2011 and 2019? Evidence from census data35
Increased availability of telehealth mental health and substance abuse treatment for peripartum and postpartum women: A unique opportunity to increase telehealth treatment34
Mechanisms of change in an adapted marijuana e-CHECKUP TO GO intervention on decreased college student cannabis use33
Increased utilization of buprenorphine and methadone in 2018 compared to 2015 among Seattle-area persons who inject drugs30
Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees29
Variability in outcomes and quality-of-care indicators across clinics participating in a large smoking-cessation program29
Racial disparities in use of non-emergency outpatient care by Medicaid-eligible adults after release from prison: Wisconsin, 2015–201729
Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration28
Law enforcement assisted diversion: Qualitative evaluation of barriers and facilitators of program implementation28
Using implementation interventions and peer recovery support to improve opioid treatment outcomes in community supervision: Protocol28
Employing the Risk-Need-Responsivity (RNR) model and predicting successful completion in an alternative drug court program: Preliminary findings from the Orleans Parish Drug Court27
Motivational interviewing telephone counseling to increase postpartum maintenance of abstinence from tobacco27
Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health26
Effects of a cannabis use disorder text message–delivered treatment on young adult alcohol misuse: Differential effects by gender26
Timing of smoking cessation treatment integrated into outpatient treatment with medications for opioid use disorder: Feasibility trial26
Emotion dysregulation and hazardous drinking in relation to suicidal ideation among Spanish-speaking Latinx daily-smokers26
Predictors and moderators of marijuana and heavy alcohol use outcomes in adolescents treated for co-occurring substance use and psychiatric disorders in a randomized controlled trial26
Optimizing outpatient treatment outcomes among methamphetamine-using gay and bisexual men through a computerized depression intervention25
Public injecting and its association with mental health and other drug-related outcomes among people who inject drugs in Iran24
Recidivism prevention for impaired driving: Longitudinal 5-year outcomes from Quebec's severity-based intervention assignment program24
Beyond harm-producing versus harm-reducing: A qualitative meta-synthesis of people who use drugs' perspectives of and experiences with the extramedical use and diversion of buprenorphine24
Mapping recovery: A qualitative node map approach to understanding factors proximal to relapse among adolescents in a recovery high school24
Barriers and facilitators of implementing integrated interventions for alcohol misuse and intimate partner violence: A qualitative examination with diverse experts24
Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention23
Rates and predictors of brief intervention for women veterans returning from recent wars: Examining gaps in service delivery for unhealthy alcohol use23
From there to here: A journey through substance use disorder, prison, and recovery23
An efficacy trial of adaptive interventions for alcohol use disorder23
Impacts of COVID-19 on residential treatment programs for substance use disorder23
COVID-19 and treating incarcerated populations for opioid use disorder23
Traditions and Connections for Urban Native Americans (TACUNA): Utilizing community-based input to develop an opioid prevention intervention for urban American Indian/Alaska Native emerging adults23
The systematic development of a mobile phone–delivered brief intervention for hazardous drinking in India22
The impact of race, gender, and heroin use on opioid addiction stigma22
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail22
Corrigendum to “Feasibility and acceptability of mindful recovery opioid use care continuum (M-ROCC): A concurrent mixed methods study” [Journal of Substance Abuse Treatment 130 (2021) 108415]21
Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals21
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island21
Community perspectives on supervised consumption sites: Insights from four U.S. counties deeply affected by opioids21
Corrigendum to “Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse” [Journal of Substance Abuse Treatment 131 (2021) 108447]21
Diagnostic remission of substance use disorders: Racial differences and correlates of remission in a nationally representative sample21
Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study20
The role of social network support in treatment outcomes for medication for opioid use disorder: A systematic review20
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder20
Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program20
Reducing tobacco use in substance use treatment: An intervention to promote tobacco-free grounds19
Race, ethnicity, and emergency department post-overdose care19
Contingency management for treatment attendance: A meta-analysis19
Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis19
Racial disparities in linkage to care among patients with substance use disorders19
Characteristics and health care events of patients admitted to treatment for both heroin and methamphetamine compared to patients admitted for heroin only19
Peer recovery services for persons returning from prison: Pilot randomized clinical trial investigation of SUPPORT19
Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic18
Poking the bear: The inapplicability of the RNR principles for justice-involved women18
Long-acting depot buprenorphine in people who are homeless: Views and experiences18
Augmenting substance use treatment in the drug court: A pilot randomized trial of peer recovery support18
Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic18
Clinical symptoms and personality traits predict subpopulations of treatment-seeking substance users18
Real-world outcomes with extended-release buprenorphine (XR-BUP) in a low threshold bridge clinic: A retrospective case series18
Acceptance of medications for opioid use disorder in recovery housing programs in Missouri18
Health care-seeking experiences for people who inject drugs with hepatitis C: Qualitative explorations of stigma18
The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial17
C2: editorial board17
Sociodemographic and clinical correlates of cannabis dependence among Israeli combat veterans17
C2: editorial board17
TOC (update)17
TOC (update)17
Emergency department utilization by individuals with opioid use disorder who were recently incarcerated17
Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail17
TOC (update)17
COVID-19 surveillance and Black American substance use disorder: An examination of data and policy16
Guidelines for authors16
SBIRT administered by mental health counselors for hospitalized adults with substance misuse or disordered use: Evaluating hospital utilization and costs16
C2: editorial board16
TOC (update)16
C2: editorial board16
‘They don't actually join the dots’: An exploration of organizational change in Irish opiate community treatment services16
C2: editorial board16
TOC (update)16
Comparative outcomes for Black children served by the Sobriety Treatment and Recovery Teams program for families with parental substance abuse and child maltreatment16
Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida15
The cascade of care for opioid use disorder among youth in British Columbia, 201815
Deaths associated with opioids, race and ethnicity, and years of potential life lost in Washington State15
Reductions in tobacco use in naltrexone, relative to buprenorphine-maintained individuals with opioid use disorder: Secondary analysis from the National Drug Abuse Treatment Clinical Trials Network15
Family involvement in treatment and recovery for substance use disorders among transition-age youth: Research bedrocks and opportunities15
Gender differences in patient outcomes following drug abuse treatment in Afghanistan: Results from a new evaluation15
Beliefs related to health care incentives: Comparison of substance use disorder treatment providers, medical treatment providers, and a public sample15
Pre-incarceration polysubstance use involving opioids: A unique risk factor of postrelease return to substance use15
Using daily diary methods to understand how college students in recovery use social support15
Adaptations to substance use disorder monitoring by physician health programs in response to COVID-1915
Mobile methadone medication units: A brief history, scoping review and research opportunity14
Multimorbidity classes indicate differential patterns of health care engagement among people who inject drugs14
Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation14
Perspectives on electronic portal use among patients treated with medications for opioid use disorder in primary care14
Effectiveness of medication for opioid use disorders in transition-age youth: A systematic review14
Value of family involvement in substance use disorder treatment: Aligning clinical and financing priorities14
Cognitive insight, medication adherence and methamphetamine cessation in people enrolled in a pharmacotherapy trial for methamphetamine use14
Comparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder14
Goal setting and monitoring with alcohol and other drug use disorders: Principles and practices14
Post–residential treatment outpatient care preferences: Perspectives of youth with opioid use disorder13
A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts13
Cascade of care for office-based buprenorphine treatment in Bronx community clinics13
Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review13
Kindness, connection, and science13
Patterns and contexts of polysubstance use among young and older adults who are involved in the criminal legal system and use opioids: A mixed methods study13
Not in my treatment center: Leadership's perception of barriers to MOUD adoption13
Characterizing nicotine withdrawal in smokers experiencing homelessness13
A cohort study examining changes in treatment patterns for alcohol use disorder among commercially insured adults in the United States during the COVID-19 pandemic13
Substance use and criminogenic thinking: Longitudinal latent class analysis of veterans with criminal histories13
An intervention pilot to facilitate harm reduction service decentralization in Vietnam13
0.047930955886841